Etiology and clinical characteristics of infantile cholestasis: a single-center retrospective study of 326 cases
Frontiers in Pediatrics · 22.04.2026 · 14
DOI: 10.3389/fped.2026.1843435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 22.04.2026. Verfasst von Yun-Ping Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, Shandong, China. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To retrospectively investigate the clinical characteristics and etiological spectrum of infantile cholestasis, with an emphasis on evolving diagnostic approaches.
Methods
Clinical data of 326 infants diagnosed with infantile cholestasis at the Children's Hospital Affiliated to Shandong University from January 2020 to December 2025 were retrospectively analyzed. Etiological distribution was systematically examined. Serum bile acid profiling was performed for suspected bile acid synthesis defects, and genetic sequencing for unexplained or suspected genetic cholestasis.
Results
Among 326 infants with infantile cholestasis, 56.7% presented with light- or clay-colored stools, 62.9% had hepatomegaly, and 8.3% had comorbidities. The etiological spectrum included biliary tract anomalies [50.6%, including 161 biliary atresia (BA)], genetic metabolic liver diseases (9.8%, n = 32), infectious causes (7.4%), drug-related causes (3.4%), idiopathic cholestasis (6.7%), other rare causes (0.9%), and undetermined etiology (21.2%). No significant differences in sex or age were observed between the genetic metabolic group ( n = 32) and BA group ( n = 161) (both P > 0.05). After excluding 165 surgical cases, genetic testing was performed in 55 of 161 remaining infants (34.2%), with pathogenic or likely pathogenic variants identified in 33 (60.0% detection rate) across 14 genes (e.g., JAG1 , SLC25A13 , ABCC2 ). In an exploratory subgroup analysis (genetic metabolic, n = 16; BA, n = 20), the BA subgroup showed significantly higher levels of matrix metalloproteinase-7 (MMP-7), direct bilirubin, and GGT ( P = 0.002 for GGT), with no other significant differences between the two subgroups.
Conclusion
The etiology of infantile cholestasis is complex and highly heterogeneous. Genetic testing improves the diagnostic yield of inherited metabolic liver diseases. Serum bile acid profiling provides metabolomic signatures for etiological differentiation. Conventional liver function tests combined with serum MMP-7 represent a simple, reliable, noninvasive approach for early differentiation of biliary atresia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, Shandong, China.
Zitieren
APA
Tang, Y. P., Wei, X. X., Xue, N., Yang, H. Y., & Li, H. (2026). Etiology and clinical characteristics of infantile cholestasis: a single-center retrospective study of 326 cases. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1843435
Vancouver
Tang YP, Wei XX, Xue N, Yang HY, Li H. Etiology and clinical characteristics of infantile cholestasis: a single-center retrospective study of 326 cases. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1843435
BibTeX
@article{Tang2026,
author = {Tang, Yun-Ping and Wei, Xu-Xia and Xue, Ning and Yang, Hai-Ying and Li, Hua},
title = {Etiology and clinical characteristics of infantile cholestasis: a single-center retrospective study of 326 cases},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1843435}
}
EUVIMED